Rubric Capital Management LP Coherus Bio Sciences, Inc. Transaction History
Rubric Capital Management LP
- $2.93 Billion
- Q1 2024
A detailed history of Rubric Capital Management LP transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 10,400,000 shares of CHRS stock, worth $18 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
10,400,000
Previous 395,207
2531.53%
Holding current value
$18 Million
Previous $1.32 Million
1788.75%
% of portfolio
0.85%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding CHRS
# of Institutions
148Shares Held
82.9MCall Options Held
184KPut Options Held
255K-
Black Rock Inc. New York, NY11.2MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$17.4 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U07.38MShares$12.8 Million0.1% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$5.25 Million0.31% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.74MShares$4.74 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $134M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...